Trinity Delta are the healthcare and life sciences specialists

Trinity Delta is the leading provider of issuer-paid equity research for the healthcare and life sciences sectors. We have an experienced, integrated team of analysts providing the highest quality services to companies and to investors. Our expertise in biotech, medtech, specialty pharma and consumer health sectors enable a deep understanding of our clients and their ambitions, which is translated into accessible, impactful and timely research, clearly outlining the investment case.

Research for all post MiFID II

Under MiFID II, whether you are an asset manager or a private investor, you can receive Trinity Delta research.

Our research is paid for by our corporate clients and we do not carry out any execution business. We do and will continue to make it freely available to all investors via multiple platforms (Trinity Delta and MiFID II).

Our Services

lited-and-private-company Listed and private company

Specialist sector research
Listed and private company coverage

active-investor Active investor

Active investor interactions
Sharing exciting investment ideas

Institutional quality reports

Institutional quality reports
Focused on what matters

Comprehensive product suite

Broad product suite
Valued by generalists and specialists

Multi-platform, global

Global distribution
Targeting a wide audience

Fully MiFID II Compliant

Fully MiFID II Compliant
Research freely available to everyone

Our Team

Our Values

We pride ourselves for our integrity and professionalism. Our word is our bond.

Integrity key to all our actions

Key to all our actions

Expertise in life sciences and related

Setting high standards

our-clients-always-come-first Our clients always come first

Clients always come first
Supporting your objectives

Trusted advisors

Trusted advisors
Collaboration and mutual respect

Our Clients